ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Clinical trials for ACUTE PROMYELOCYTIC LEUKEMIA (APL) explained in plain language.
Never miss a new study
Get alerted when new ACUTE PROMYELOCYTIC LEUKEMIA (APL) trials appear
Sign up with your email to follow new studies for ACUTE PROMYELOCYTIC LEUKEMIA (APL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an arsenic drink replace IV drips for leukemia patients?
Disease control CompletedThis study tested an oral liquid form of arsenic trioxide (SDK001) in 12 people with acute promyelocytic leukemia (APL). Researchers compared how well the body absorbs the oral drug versus the standard IV version, and whether food or calcium supplements change absorption. The goa…
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Phase: PHASE1 • Sponsor: SDK Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
AI boosts cancer diagnosis speed in small study
Knowledge-focused CompletedThis study tested whether artificial intelligence (AI) can help doctors diagnose a rare blood cancer called acute promyelocytic leukemia (APL) more quickly and accurately. Ten doctors reviewed bone marrow samples with and without AI assistance. The goal was to see if AI improves …
Matched conditions: ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Phase: NA • Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC